Literature DB >> 2826056

Processing and presentation of cell-associated varicella-zoster virus antigens by human monocytes.

O Pontesilli1, P Carotenuto, M J Levin, D Suez, A R Hayward.   

Abstract

To determine whether viral antigens associated with infected cells were processed for presentation to T cells, we cultured human blood mononuclear cells (MNC) from varicella-zoster virus (VZV) immune donors with VZV-infected fibroblasts of known HLA type which had been fixed in 0.05% glutaraldehyde. After 7-8 days of culture thymidine uptake by T4+ cells exceeded that of T8+ cells. Stimulated cells were depleted of adherent cells and restimulated with VZV-infected fibroblasts from donors matched or unmatched with the responder for HLA type in the presence or absence of fresh adherent cells. Proliferation of the VZV-specific blasts required the presence of adherent cells matched with the responder lymphocytes for HLA-DR; conversely, the VZV specific response was not restricted by the MHC of the fibroblasts used in the restimulation assay. Preincubation of the adherent cells with chloroquine inhibited the proliferative response in a dose-dependent manner. These results suggest that VZV antigens on infected cells may be processed by monocytes for presentation to T cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2826056      PMCID: PMC1542223     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells.

Authors:  J A Zaia; M N Oxman
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

2.  Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity.

Authors:  R R Herberman; J R Ortaldo; G D Bonnard
Journal:  Nature       Date:  1979-01-18       Impact factor: 49.962

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Interleukin-2 augments natural killer cell activity.

Authors:  C S Henney; K Kuribayashi; D E Kern; S Gillis
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

5.  Specific in vitro antibody response to varicella zoster.

Authors:  R L Souhami; J Babbage; R E Callard
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

6.  Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants.

Authors:  F M Brodsky; P Parham
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

7.  Human T cell clones specific for tetanus toxoid: characterization of antigen specificity and HLA restriction.

Authors:  C Schmitt; J J Ballet; M Agrapart; B Bizzini
Journal:  Eur J Immunol       Date:  1982-10       Impact factor: 5.532

8.  Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.

Authors:  E G Engleman; C J Benike; F C Grumet; R L Evans
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

9.  Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing.

Authors:  R Shimonkevitz; J Kappler; P Marrack; H Grey
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

10.  In vitro antigen-induced, antigen-specific antibody production in man. Specific and polyclonal components, kinetics, and cellular requirements.

Authors:  H C Lane; D J Volkman; G Whalen; A S Fauci
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Antigen presenting cells.

Authors:  D L Hamilos
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Inhibition of varicella-zoster virus in vitro by human peripheral blood mononuclear cells.

Authors:  G P Rabalais; F E Berkowitz; A R Hayward; M J Levin
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

3.  T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV.

Authors:  A R Hayward
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Major histocompatibility complex restriction of T-cell responses to varicella-zoster virus in guinea pigs.

Authors:  A R Hayward; R Burger; R Scheper; A M Arvin
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

Review 5.  Th1 regulatory events by infectious pathogens, herpes zoster and herpes simplex viruses: prospects for therapeutic options for atopic eczema.

Authors:  Yasuhiro Horiuchi
Journal:  Postepy Dermatol Alergol       Date:  2022-09-01       Impact factor: 1.664

Review 6.  Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century.

Authors:  Jean-Marc Rolain; Philippe Colson; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2007-07-16       Impact factor: 5.283

Review 7.  Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy.

Authors:  Laurel C Chandler; Imran H Yusuf; Michelle E McClements; Alun R Barnard; Robert E MacLaren; Kanmin Xue
Journal:  Int J Mol Sci       Date:  2020-07-14       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.